Technology

Hong Kong-based Insilico, which uses machine learning to identify potential drug targets, raised $35M from Prosperity7, bringing its total Series D to $95M (Rita Liao/TechCrunch)

[ad_1]

Rita Liao / TechCrunch:

Hong Kong-based Insilico, which uses machine learning to identify potential drug targets, raised $35M from Prosperity7, bringing its total Series D to $95M  —  Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.”



[ad_2]

Share this news on your Fb,Twitter and Whatsapp

File source

Times News Network:Latest News Headlines
Times News Network||Health||New York||USA News||Technology||World News

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close